Van Nevel Retires as NCI Communications Chief

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 2
Volume 9
Issue 2

BETHESDA, Md-J. Paul Van Nevel ended a 26-year career at the National Cancer Institute on Dec. 31, when he retired as associate director for cancer communications. He immediately began a new career as a communications consultant, with NCI as a client.

BETHESDA, Md—J. Paul Van Nevel ended a 26-year career at the National Cancer Institute on Dec. 31, when he retired as associate director for cancer communications. He immediately began a new career as a communications consultant, with NCI as a client.

NCI director Richard D. Klausner, MD, praised Mr. Van Nevel at the National Cancer Advisory Board meeting and thanked him for his contributions to the Institute. Dr. Klausner noted that Mr. Van Nevel would “help us negotiate the transition to the post-Paul Van Nevel era at NCI.”

Mr. Van Nevel joined NCI as deputy director of communications in 1973, following 5 years in media relations at Johns Hopkins. He was named head of NCI’s communications office in 1974. Nelvis Castro, chief of NCI’s health promotion branch, will serve as acting associate director for cancer communications.

Recent Videos
Lisa J. States, MD, discussed further steps for improving early detection and screening methods in patients with Li–Fraumeni syndrome.
STX-478 may avoid adverse effects associated with prior PI3K inhibitors that lack selectivity for the mutated protein vs the wild-type protein.
9 Experts are featured in this series.
9 Experts are featured in this series.
Additional genetic testing measures and targeted therapies may improve outcomes for patients with diverse molecular subgroups of gastric cancers.
Phase 1 data may show the possibility of rationally designing agents that can preferentially target PI3K mutations in solid tumors.
Funding a clinical trial to further assess liquid biopsy in patients with Li-Fraumeni syndrome may help with detecting cancers early across the board.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
Related Content